PDS Biotechnology Corporation (PDSB)
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.
$118.19M
Dr. Frank K. Bedu-Addo Ph.D.
22.00
Florham Park, NJ
Oct 01, 2015
-2.61
$-1.23
3.68
3.84
0.00%
-2.90
-0.05
3.81
0.00
3.84
-67.24%
-137.06%
Similar stocks (10)
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
Inozyme Pharma, Inc.
INZY
HOOKIPA Pharma Inc.
HOOK
X4 Pharmaceuticals, Inc.
XFOR
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
Enveric Biosciences, Inc.
ENVB
CohBar, Inc.
CWBR
eFFECTOR Therapeutics, Inc.
EFTR
ETF Exposure (15)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.51%
iShares Micro-Cap ETF
IWC
0.02661%
Dimensional U.S. Small Cap ETF
DFAS
9.163e-5%
Dimensional U.S. Core Equity 2 ETF
DFAC
4.3939999999999996e-5%
Dimensional US Core Equity Market ETF
DFAU
3.9e-7%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (10)
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
Inozyme Pharma, Inc.
INZY
HOOKIPA Pharma Inc.
HOOK
X4 Pharmaceuticals, Inc.
XFOR
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
Enveric Biosciences, Inc.
ENVB
CohBar, Inc.
CWBR
eFFECTOR Therapeutics, Inc.
EFTR
ETF Exposure (15)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.51%
iShares Micro-Cap ETF
IWC
0.02661%
Dimensional U.S. Small Cap ETF
DFAS
9.163e-5%
Dimensional U.S. Core Equity 2 ETF
DFAC
4.3939999999999996e-5%
Dimensional US Core Equity Market ETF
DFAU
3.9e-7%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%